Aeglea BioTherapeutics
spy is a potentially best in class anti a with near term risking studies anticipated on | Aeglea BioTherapeutics
Deck date
July 2023
Slide
36 of 56
Similar slides by Aeglea BioTherapeutics
Investor Presentation
September 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Mergers and Acquisitions
June 2023
Related slides by other companies
Investor Presentation
October 2024
Investor Presentation
May 2023
IPO
October 2020
Results
October 2023
Other recent decks by Aeglea BioTherapeutics
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Mergers and Acquisitions
June 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2024 Slidebook.io